Novel drug shows hemodynamic benefits in patients across heart failure spectrumtranslating…

MUNICH — A novel oral relaxin receptor agonist was well tolerated and had favorable effects on hemodynamics in patients with heart failure across the ejection fraction spectrum, researchers reported.